Full-Life Expands Radiopharmaceutical Reach With $245m Focus-X Buyout

Area Attracting Investors

acquisition deal
Asset acquisition helping Chinese biotechs gain traction in radiopharmaceuticals push • Source: Shutterstock

More from China

More from Focus On Asia